Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-146-1 | CAS number: 1141487-54-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012-10-26 to 2013-02-06
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2012
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Version / remarks:
- adopted 1996-03-22
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- signed 2012-02-13
- Limit test:
- no
Test material
- Reference substance name:
- (R,S)-5-cyclohexyl-2-methyl-pentan-1-ol
- EC Number:
- 700-146-1
- Cas Number:
- 1141487-54-8
- Molecular formula:
- C12H24O
- IUPAC Name:
- (R,S)-5-cyclohexyl-2-methyl-pentan-1-ol
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 11-12 Weeks
- Weight at study initiation: males: 252.81 to 350.93 g; females: 188.74 to 240.78 g
- Housing:
premating: two rats of same sex were housed per cage in sterilized standard polysulfone cages (Size: L 425 x B 266 x H 175 mm), with stainless steel top grill
mating: two rats (one male and one female) were housed in standard polysulfone cages with stainless steel top grill
post mating: males were housed with their former cage mates; females were housed individually in polysulfone cages
- Sterilised nesting material (paper shreds) was provided near-term.
- Steam sterilized clean Corn cob was used as bedding.
- Diet (ad libitum): Teklad Certified (2014C) Global 14 % Protein Rodent Maintenance Diet - Pellet (Certified)
- Water (ad libitum): deep bore-well water passed through activated charcoal filter and exposed to UV rays in ‘Aquaguard’ on-line water filter-cum-purifier
- Acclimation period: five days
ENVIRONMENTAL CONDITIONS
- Temperature: between 20 and 24°C
- Relative humidity: between 49 and 67 percent
- Air changes: 12.8 – 13.7 air changes/hour
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Required quantities of the test item was weighed in beakers and mixed with a small quantity of corn oil and stirred using a glass rod. The mixture was
transferred into the measuring cylinder. The volume was made up with the vehicle to get the final concentration of 20, 60 and 200 mg/mL for the G2, G3 and G4/G4R groups, respectively.
Following procedure was followed when 50 mL of dose formulation prepared:
The quantities of 1.0, 3.0 and 10.0 g of test item was weighed and mixed with a small quantity of corn oil. The mixture was transferred into the measuring cylinder. The volume was made up to 50 mL with the vehicle to get the final concentration of 20, 60 and 200 mg/mL for the G2, G3 and G4/G4R groups, respectively.
The suspension was stirred during sampling/gavage.
VEHICLE
- Justification for use and choice of vehicle: corn oil was used as vehicle for dose formulation preparation as the same vehicle was used in the dose range finding toxicity study.
In the dose range finder it was mentioned that the test item forms clear solution in corn oil, while it could not be dissolved/suspended in water, 0.5% aqueous sodium carboxy methyl cellulose in Milli Q water with 0.1% tween 80. - Details on mating procedure:
- - M/F ratio per cage: 1:1 ratio
- Length of cohabitation: until there is evidence of sperms in the vaginal smear and /or vaginal plug or for a maximum period of 2 weeks
- Proof of pregnancy: vaginal plug / sperm in vaginal smear referred to Gestation Day 0
- After 14 days of unsuccessful pairing replacement of first male by another male with proven fertility
- After successful mating each pregnant female was caged (how): individually
- pre-coital time was calculated for each female - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- For homogeneity and test item concentration analysis, the prepared dose suspension was sampled in duplicate sets (two samples were drawn from each of
the top, middle and bottom layers for each set) from each dose levels on Day 1 and during 2nd month of the treatment period. Similarly, two samples from
middle layer were drawn from vehicle control for each set.
The estimation of the test item in the dose formulations was carried out by injecting the prepared sample solutions into Gas Chromatograph equipped with Flame Ionization Detector (GC-FID).
Results:
The test item was found to be homogeneous in all the dose formulation samples which met the acceptance limits of variation (85 to 115%) from the claimed concentrations and % RSD less than 10 %.
Based on the results, the test item was found to be stable for up to 24 hours at 1 and 200 mg/mL concentrations when stored at room temperature. - Duration of treatment / exposure:
- - Males: 2 weeks prior to mating, during mating and up to and including the day before sacrifice which was done after the completion of the mating process (but at least a minimum period of four weeks).
- Females: 2 weeks prior to the mating period, during mating, pregnancy and up to lactation day 4 - Frequency of treatment:
- Males and females: once daily at approximately the same time each day (varying by ± 2 hours)
- Details on study schedule:
- not applicable
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 100, 300, and 1000 mg/kg/day
Basis:
actual ingested
- No. of animals per sex per dose:
- 10 males / 10 females
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- DOSE RANGE FINDER STUDY (Malleshappa, 2012)
- Dose selection rationale: the dose levels of 100, 300 and 1000 mg/kg/day were selected for this study based on the results of 14-Day Repeated Dose Oral Toxicity Study in Wistar Rats and in consultation with the Sponsor.
The test item was weighed and dissolved in corn oil and administered to rats at the graduated dose levels of 100, 300 and 1000 mg/kg/day via oral gavage once daily for a period of 14 consecutive days. The rats in the vehicle control group received vehicle alone. The dose volume administered was 5 mL/kg body weight. Each group in the experiment was comprised of five male and five female rats.
All animals were observed for clinical signs (once daily) and mortality/morbidity (twice daily, except on holidays). Ophthalmological examination was performed before the start of treatment period and at the end of treatment. Body weights were measured on Days 1, 4, 8, 11 and 14 of treatment period and food consumption was measured on Days 4, 8, 11 and 14. On Day 15 of treatment, blood samples were collected for haematology and clinical chemistry. The rats were fasted overnight (water allowed) and subjected to a detailed necropsy and study plan specified organs were collected and weighed.
Results:
- no clinical sign or mortality in any of the groups during the experimental period.
- no ocular abnormalities were observed in animals of either sex of test item treated groups.
- mean body weights, body weight gain and food consumption of test item treated groups were comparable to vehicle control group during the treatment period.
- no test item-related changes in the various parameters evaluated in haematology, coagulation analysis and clinical chemistry.
- no test item-related changes in the terminal fasting body weights, organ weights and organ weight ratios in treated group animals when compared to the vehicle control group.
- no test item-related gross pathological changes among the doses tested. - Positive control:
- no data
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: once daily (1 to 2 hours after dosing), except mortality and morbidity, which was observed twice daily (once on holidays)
- Cage side observations checked: appearance, behaviour, clinical/toxic signs, mortality and morbidity
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: prior to initiation of treatment and at weekly intervals during treatment and recovery periods
BODY WEIGHT: Yes
- Time schedule for examinations:
- Males: initially and at weekly intervals thereafter
- Females: initially and at weekly intervals thereafter till cohabitation with males; Gestation Days (GD) 0, 7, 14 and 20 and on lactation days 0 and 4
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No
WATER CONSUMPTION AND COMPOUND INTAKE: No
PARTURITION:
- The duration of gestation was calculated from day ‘0’ of pregnancy to the day of parturition (Gestation Length).
- Females were observed for signs of difficult or prolonged parturition. - Oestrous cyclicity (parental animals):
- no data
- Sperm parameters (parental animals):
- Histopathological examination of testes also included a qualitative assessment of stages of spermatogenesis (5 males in the control and high dose groups).
- Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: not applicable
PARAMETERS EXAMINED
The following parameters were examined in F1 offspring:
- external deformities (dead and alive births)
- number and sex of pups
- pup body weight (days 0 and 4 post-partum)
- daily observations of the number of alive, dead and cannibalized pups - Postmortem examinations (parental animals):
- SACRIFICE
All rats in this study were sacrificed at term after overnight fasting. Rats were anaesthetized with isoflurane, weighed and exsanguinated and subjected to detailed necropsy.
- males: after mating process
- females: on lactation day 5
HISTOPATHOLOGY / ORGAN WEIGHTS
- The following tissues were prepared for microscopic examination (all adult animals): all gross lesions, epididymides, ovaries, uterus (with oviducts and cervix), vagina, prostate, seminal vesicles and coagulating glands, and testes
- The following tissues were prepared for organ weighing (all adult animals): epididymides, ovaries, uterus (with oviducts and cervix), prostate, seminal vesicles and coagulating glands, and testes
- The following tissues were prepared for microscopic examination (5 males / 5 females from main groups and all animals from recovery group): axillary lymph nodes, adrenals, brain (cerebrum, cerebellum and pons), bone marrow smear, cecum, colon, duodenum, femur with marrow, heart, ileum with Peyer’s patches, jejunum, kidneys, liver, lungs, mandibular lymph nodes, mesenteric lymph nodes, rectum, sciatic nerve, spinal cord, spleen, sternum with marrow, stomach, thymus, thyroid with parathyroid, trachea, and urinary bladder
- The following tissues were prepared for organ weighing (5 males / 5 females from main groups and all animals from recovery group): adrenals, brain (cerebrum, cerebellum and pons), heart, kidneys, liver, spleen, thymus, and thyroid with parathyroid
Tissues collected from randomly selected 5 males and 5 females in the control and high dose groups were examined microscopically for histopathological changes. The uterus, cervix and vagina were examined in the remaining females from control and high dose groups.
For apparently non-pregnant rats, the uteri were stained with ammonium sulphide solution to identify the pre-implantation loss of the embryos. The
number of implantation sites and corpora lutea was recorded for all the dams. - Postmortem examinations (offspring):
- SACRIFICE
- All surviving pups were sacrificed on lactation Day 4.
GROSS NECROPSY
- All surviving pups were necropsied on lactation Day 4. Dead and moribund pups were examined for possible defects and/or cause of
death. - Statistics:
- The statistical analysis of the experimental data was carried out using the validated package in Excel and also using licensed copies of SYSTAT Statistical
package ver.12.0. All quantitative variables like body weight, food intake, organ weights and organ weight ratios were tested for normality (Shapiro-Wilk test) and homogeneity of variances (Levene’s test) within the group before performing a one-factor ANOVA modeling by treatment groups. Non-optimal (non-normal or heteroschedastic) data was transformed, before ANOVA is performed. Comparison of means between treatment groups and control group was done using Dunnett’s test when the overall treatment, ‘F’ test found significant.
Pre-implantation loss (%), post implantation loss (%), no. of corpora lutea and implantations, pre-coital interval and gestation length (days) were analysed after
suitable transformation (√ x + ½) of the data. One-way analysis of variance (ANOVA) was carried out for the transformed data. Dunnett’s pair-wise comparison of the treated means with the control mean was done when the group differences are found significant.
Z test was performed for testing the differences in proportions for mating and fertility indices.
All analyses and comparisons were evaluated at the 5% (P≤0.05) level. - Reproductive indices:
- - male mating index (%) = (number of males with evidence of mating/number of males cohabited) x 100
- male fertility index (%) = (number of males siring a litter/number of males cohabited) x 100
- female mating index (%) = (number of females mated/number of females cohabited) x 100
- fecundity index (%) = (number of pregnant females (confirmed at necropsy)/ number of females with confirmed mating) x 100
- female fertility index (%) = (number of pregnant females (confirmed at necropsy)/number of females used for mating) x 100
- mean number of corpora lutea (CL)/group = total number of CL/total number of pregnant animals
- mean number of implantations/group = total number of implantations / total number of pregnant animals
- implantation index = (No. of implantation sites/No. of corpora lutea) x 100
- percentage of pre-implantation loss per group = (number of CL - number of implantations / number of CL) x 100
- post implantation loss (%) = ((number of implantations - number of live foetuses/pups) / number of implantations) x 100
- gestation index = (number of females with live pups born / number of females with evidence of pregnancy (confirmed at necropsy)) x 100 - Offspring viability indices:
- - mean litter size per group = (total number of foetuses/pups) / total number of pregnant /littered animals
- live birth index (%) = (number of viable pups born (at first observation) / total number of pups born (at first observation)) x 100
- Day 4 survival index (%) = (number of viable pups on lactation Day 4 / number of viable pups born) x 100
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Other effects:
- not examined
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- effects observed, treatment-related
Details on results (P0)
- no clinical signs or mortality was observed during the course of the study.
BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS)
- body weights and food consumption were not test item-related affected at all the doses tested; significantly decreased body weight on GD20 and weight changes during gestation (GDs 0-7, 14-20 and 0-20) were correlated with lower mean litter size and thus not a sign of systemic toxicity.
- maternal food consumption during gestation was not affected by the treatment at all the doses.
- maternal body weights and food consumption during lactation periods were unaffected at all the doses tested.
REPRODUCTIVE FUNCTION: SPERM MEASURES (PARENTAL ANIMALS)
- spermatogenesis was normal.
REPRODUCTIVE PERFORMANCE (PARENTAL ANIMALS)
- 100 and 300 mg/kg Bwt/day doses: no treatment-related effects on the mean pre-coital time and gestation length.
- 100 and 300 mg/kg Bwt/day doses: no treatment-related changes were observed in the uterine/implantation data.
- 1000 mg/kg Bwt/day dose: treatment resulted in significantly increased mean precoital time and mean gestational length.
- 1000 mg/kg Bwt/day dose: treatment significantly increased the post- implantation loss, and a significantly lower gestation index was found.
- no treatment-related changes were observed on the fertility indices of sires and dams.
ORGAN WEIGHTS (PARENTAL ANIMALS)
- no test item related changes in the organ weights and organs weight ratios in both males and females.
GROSS PATHOLOGY (PARENTAL ANIMALS)
- no test item related gross changes in both males and females.
HISTOPATHOLOGY (PARENTAL ANIMALS)
- no test item related microscopic changes in both males and females.
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- 1 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: No clinical signs, mortality and neurological dysfunctions; no effectson on body weight and food consumption; no changes in haematology, clinical chemistry and urinalysis; no effects on organ weights, pathology and histopathology.
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- not specified
- Mortality / viability:
- mortality observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not specified
Details on results (F1)
- 100 and 300 mg/kg Bwt/day doses: no treatment-related effects on the mean litter size and mean viable litter size at the .
- 1000 mg/kg Bwt/day: treatment significantly decreased the mean litter size, mean viable litter size and live birth index due to higher post-implantation loss.
- Day 4 survival index was significantly lower at all the tested doses. The decreased Day 4 survival index was mainly due to the total death/cannibalism of pups observed in two dams on Day 1 at the 100 mg/kg Bwt/day and cannibalism of 6/11 and 6/13 pups in two dams at the 300 mg/kg Bwt/day doses. The changes observed at 100 and 300 mg/kg Bwt/day doses were considered an incidental finding.
BODY WEIGHT (OFFSPRING)
- mean body weight of male and female pups per litter were not affected by the treatment at 100 and 300 mg/kg Bwt/day doses.
- mean weight of female and total pups was also decreased on LD 0, when compared to vehicle control.
GROSS PATHOLOGY (OFFSPRING)
- no gross pathology findings in both males and female pups.
OTHER FINDINGS (OFFSPRING)
- mean number of male and female (and total number) pups per litter were not affected by the treatment at 100 and 300 mg/kg Bwt/day doses. At 1000 mg/kg Bwt/day, the treatment significantly decreased the mean number of male, female and total pups on LDs 0 and 4.
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Remarks:
- preliminary (screening study)
- Generation:
- F1
- Effect level:
- 300 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- Oral administration of the test item to male and female Wistar rats prior to mating, during mating and post mating periods (for males), during pregnancy and up to lactation day 4 (for females) at the dose levels 100, 300 and 1000 mg/kg bw./day had no treatment-related effects on general health, body weights and food intake, terminal body weights, organ weights and organs weight ratios. There were no test item-related gross and microscopic changes in both males and females.
At the 1000 mg/kg bw/day, the treatment resulted in significantly higher mean gestation length and pre-coital time, significantly lower body weights of dams during the gestation period, lower mean number of male, female and total pups on LDs 0 and 4. The mean weight of female and total pups was also decreased on LD 0, when compared to the vehicle control. The observation of lower mean litter size, mean viable litter size and live birth index was due to the higher postimplantation loss. Day 4 survival and gestation index were also significantly lower due to higher dead/cannibalism of pups observed. No effects on reproduction were observed at lower dose levels of 100 and 300 mg/kg bw/d.
NOAEL (P-generation, male and female): 1000 mg/kg bw/day
NOAEL (reproduction/development): 300 mg/kg bw/day (preliminary)
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)